Study sheds light on weight regain after GLP-1 discontinuation
Many patients may keep off lost pounds after stopping a GLP-1, US data suggests – Reuters
Many patients may keep off lost pounds after stopping a GLP-1, US data suggests Reuters
Why Environment Matters More When Using GLP-1 Medications
GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits more than motivation alone.
Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug
In a reminder of the money still available for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in series D funds to bankroll phase 2 studies of its oral GLP-1 receptor agonist.
What happens after GLP-1s and why food will matter more than ever
A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.
China-founded pharma Corxel raises up to $287M for oral GLP-1
Since its 2019 founding, Corxel Pharmaceuticals has evolved from focusing on the China market to eyeing the world. The biopharma, founded in Shanghai but now headquartered in New Jersey, has raised as much as …
Off the Scales: ‘meticulously reported’ rise of Ozempic
In 2024, the US Centers for Disease Control and Prevention published “what could well be the most important table in modern public health”, said Tom Whipple in The Times. For decades, American waistlines had been expanding “inexorably”. But the 2024 assessment of “how fat the country was” revealed a change: the “number of fat people […]
China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions – Endpoints News
China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions Endpoints News
CoreAge Rx Introduces Flat-Rate Pricing for GLP-1 Medications
WICHITA FALLS, Texas, Jan. 22, 2026 /PRNewswire/ — CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed to eliminate hidden fees and provide predictable costs for patients seeking GLP-1 medications. The company now…
Simply Good Foods turns again to ex-CEO amid GLP-1 advance
The US group has re-hired former CEO Joe Scalzo as sales falter and as GLP-1 trend presents opening for Atkins brand.